In addition, in a Chinese NSCLC cohort, it was also confirmed that the TP53/KRAS subgroup manifested exclusive increased expression of PD-L1 and a highest proportion of PD-L1+/CD8A+ [39]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.